Patents by Inventor Camille Gleason

Camille Gleason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations
    Patent number: 10653781
    Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: May 19, 2020
    Assignee: AMGEN INC.
    Inventors: Christopher James Sloey, Camille Gleason, Jason Ko, Tiansheng Li
  • PHARMACEUTICAL FORMULATIONS
    Publication number: 20170049895
    Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.
    Type: Application
    Filed: April 1, 2016
    Publication date: February 23, 2017
    Inventors: Christopher James Sloey, Camille Gleason, Jason Ko, Tiansheng Li
  • REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS
    Publication number: 20130171128
    Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from taurine, theanine, sarcosine, citrulline and betaine.
    Type: Application
    Filed: March 1, 2011
    Publication date: July 4, 2013
    Applicant: AMGEN INC.
    Inventors: Holly Zhuohong Huang, Dingjiang Liu, Christopher J. Sloey, Camille Gleason